Chairs and Committees

Global Forum Co-Chairs

  • David Lewinsohn, Stop TB Partnership Working Group on New TB Vaccines, Oregon Health & Science University (USA)
  • Mark Feinberg, IAVI (USA)
  • Nick Drager, TuBerculosis Vaccine Initiative (Netherlands)
  • Olivier Neyrolles, CNRS (France)

Planning Committee

  • Jennifer Woolley, Global Forum on TB Vaccines (USA)
  • Marit Holleman, TBVI (Netherlands)
  • Hester Kuipers, IAVI (Netherlands)
  • Gabrielle Quintard, IAVI (USA)
  • Shaun Palmer, IAVI (Netherlands)
  • Isabelle Saves, IPBS (France)
  • Francoise Viala, IPBS (France)

 

Organizing Committee

  • Sam Behar, University of Massachusetts Medical School (USA)
  • Patrick Bertrand, Global Health Advocates/Action Santé Mondiale (France)
  • Patricia Darrah, NIH Vaccine Research Center (USA)
  • Katrin Eichelberg, NIAID-NIH (USA)
  • Ann M. Ginsberg, Bill & Melinda Gates Foundation (USA)
  • Willem Hanekom, AHRI (South Africa)
  • Simone A. Joosten, Department of Infectious Diseases, Leiden University Medical Center (Netherlands)

 

  • Rasmus Mortensen, Statens Serum Institut (Denmark)
  • Michele Tameris, South African Tuberculosis Vaccine Initiative, University of Cape Town (South Africa)
  • Dereck Tait, IAVI (South Africa)
  • Richard G. White, LSHTM (UK)
  • Gerald Voss, TuBerculosis Vaccine Initiative (Belgium)

ADVISORY PANEL

  • Fareed Abdullah, South African Medical Research Council (South Africa)
  • Roland Brosch, Institut Pasteur (France)
  • Sang Nae Cho, Yonsei University College of Medicine (South Korea)
  • Gavin Churchyard, Aurum Institute (South Africa)
  • Frank Cobelens, Amsterdam Institute for Global Health and Development (Netherlands)
  • Mark Cotton, Stellenbosch University (South Africa)
  • Alejandro Cravioto,  Universidad Nacional Autónoma de México (Mexico)
  • Lucica Ditiu, Stop TB Partnership (Switzerland)
  • Anca Dorhoi, Friedrich-Loeffler-Institut (Germany)
  • Mike Frick, Treatment Action Group (New York)
  • Brigitte Gicquel, Shenzhen Nanshan CCDC (China)
  • Michelle Helinski, EDCTP (Netherlands)
  • Anneke Hesseling, Stellenbosch University (South Africa)
  • Stefan H.E. Kaufmann, Max Planck Institute for Infection Biology (Germany)
  • Andreas Kupz, Australian Institute of Tropical Health and Medicine, James Cook University (Australia)
  • Luciana C. C. Leite, Instituto Butantan (Brazil)
  • Haiying Liu, Chinese Academy of Medical Sciences/Peking Union Medical College (China)
  • Camille Locht, Inserm (France)

 

  • Carlos Martin, Universidad de Zaragoza (Spain)
  • Katrin Mayer-Barber, NIAID/NIH (USA)
  • Souleymane Mboup, IRESSEF (Senegal)
  • Helen McShane, University of Oxford (UK)
  • Elisa Nemes, South African Tuberculosis Vaccine Initiative, University of Cape Town (South Africa)
  • Doreen Pamba, National Institute for Medical Research-Mbeya Medical Research Centre (NIMR-MMRC) (Tanzania)
  • Louis J. Picker, Oregon Health & Science University (USA)
  • Niaina Rakotosamimanana, Institut Pasteur de Madagascar (Madagascar)
  • Issa Sabi, National Institute for Medical Research (NIMR) (Tanzania)
  • Alexander Schmidt, Gates Medical Research Institute (USA)
  • Steffen Stenger, University Hospital, Ulm (Germany)
  • Jamie Triccas, The University of Sydney (Australia)
  • Kenneth Barry Walker, Independent Consultant (Australia)
  • Robert J. Wilkinson, The Wellcome Centre for Infectious Diseases Research in Africa (South Africa)
  • Matteo Zignol, Global Tuberculosis Programme, World Health Orgnization (Switzerland)